PHOENIX BIOTECH SPONSOR LLC 13D and 13G filings for CERo Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-20 5:18 pm Sale | 2024-02-14 | 13D | CERo Therapeutics Holdings, Inc. CERO | PHOENIX BIOTECH SPONSOR LLC | 508 6.800% | -2,141 (-80.84%) | Filing |
| 2023-01-31 6:40 pm Unchanged | 2023-01-27 | 13D | CERo Therapeutics Holdings, Inc. CERO | PHOENIX BIOTECH SPONSOR LLC | 2,648 78.200% | 0 (Unchanged) | Filing |
| 2022-02-08 4:00 pm Purchase | 2021-12-31 | 13G | CERo Therapeutics Holdings, Inc. CERO | PHOENIX BIOTECH SPONSOR LLC | 2,648 23.000% | 2,648 (New Position) | Filing |